Stay updated with breaking news from Longevity Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FOXO Technologies Inc. , a leader in the field of commercializing epigenetic biomarker technology, today reported financial results for the second quarter ended June 30, 2023. “I am very proud of... -Today at 04:16 pm- MarketScreener
FOXO Technologies Inc.™ , a leader in commercializing epigenetic biomarkers of health and aging, today announced the direct-to-consumer launch of its beta version wellness product, the FOXO... | April 18, 2023
Content: Members Page For Bernard Starr - Members Page For Bernard Starr
Scheme liabilities could reduce by 2% as mortality rates continue to increase due to the cost of living crisis and the effects of the pandemic, according to Lane Clark & Peacock (LCP).